It's medical device, not a drug. The device got approved for some cancer indications, under research for other cancer indications as well, etc. And look at the revenue from the indication where it got approved. Very poor.. almost negligible, not capable of making significant revenue. If it would be a drug, it would be a $100/sh now. That's the difference between a device and a drug.
offerings and common stock from open market are totally different, if you don't know that you should not be trading stocks.
PBTI is not like VLTC, instead it's a biotech with strong product portfolio in cancer market place. Two already approved, several in pipe line. Huge revenue growth near term. Today is the beginning, this stock worth $750M to $1B market cap in 8 to 10 months. imo
Sentiment: Strong Buy
If a company is successful then only a bigger company buys it. For example Open Table - very successful so Price Line bought it, GenenTech - super successful, so Roche bought it. That's the process. No one will ever buy a failed company. Sorry longs, there will be absolutely no buy out, you longs are screwed.
That's the fair value I give to it, until it goes there no buyout will happen.